Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ Human SARS-CoV-2 Spike (Trimer) IgG ELISA Kit

Click to view available options
Quantity:
10 x 96 Tests
2 x 96 Tests
5 x 96 Tests
96 Tests
Description
It has recently been shown that SARS (severe acute respiratory syndrome) is caused by a human coronavirus. Human coronaviruses are the major cause of upper respiratory tract illness, such as the common cold, in humans. Coronaviruses are positive-stranded RNA viruses, featuring the largest viral RNA genomes known to date (27-31 kb). The first step in coronavirus infection is binding of the viral spike protein, a 139-kDa protein, to certain receptors on host cells. The spike protein is the main surface antigen of the coronavirus. The glycosylated spike protein (as well as the nucleocapsid protein) can be detected in infected cell culture supernatants with antisera from SARS patients.

Specifications
Specifications
Assay Range | 234 to 15,000 Units/mL |
Assay Sensitivity | <39 Units/mL |
Conjugate | HRP |
Product Type | ELISA |
Sample Type | Plasma, Serum |
For Use With (Equipment) | Colorimetric Microplate Reader |
Gene Alias | Coronavirus; COVID; Covid 19; COVID19; COVID-19; SARS; SARS Coronavirus; SARS CoV; SARS CoV2; SARS CoV-2; SARS Spike Protein; SARS-CoV-2 |
Interassay CV | <10% |
Intraassay CV | <10 |
Kit Contents | Pre-coated 96 well plate, High Control (standard), Calibrator (medium control), Low Control, IgG - HRP conjugate, Assay Buffer concentrate, Wash Buffer concentrate, Substrate solution, Stop Solution, Adhesive Plate Covers |
Show More |
Product Content Correction
The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction